ArticleDiabetology & metabolic syndrome2021

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.

Sachiko Hattori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.